However, the molecular mechanisms by which nuclear CDK5 acts as a tumor suppressor are largely unknown in gastric cancer, except for one study that showed that nuclear CDK5 upregulates the levels of the CDK inhibitor p16INK4a, which contributes to cell cycle arrest [40] (Fig. 3B). This evidence concerns the gene CDK5 and neoplasm.